This inventor holds 2 USPTO granted patents. Top assignees: General Electric Company, Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.. Active years: 2018-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2018-2025
Title: Jianguo Xiao: Innovator in Therapeutic and Amplification Technologies
Introduction
Jianguo Xiao is a prominent inventor based in Shanghai, China. He has made significant contributions to the fields of therapeutic drugs and electronic amplification technologies. With a total of two patents to his name, his work reflects a commitment to innovation and practical applications.
Latest Patents
One of Jianguo Xiao's latest patents is a method for preparing recombinant human nerve growth factor. This method can be utilized as a therapeutic drug, showcasing his dedication to advancing medical science. Another notable patent is a switching amplifier with zero voltage switching and a balanced thermal control algorithm. This invention includes multiple cascade elements and bridge circuits, designed to optimize energy storage and minimize circulating current, thereby enhancing the efficiency of electronic devices.
Career Highlights
Throughout his career, Jianguo Xiao has worked with notable companies, including General Electric Company and Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to his success as an inventor.
Collaborations
Jianguo Xiao has collaborated with talented individuals such as Ying Mei and Pengcheng Zhu. These partnerships have likely enriched his work and fostered a collaborative environment for innovation.
Conclusion
Jianguo Xiao's contributions to the fields of therapeutic drugs and electronic technologies highlight his role as a significant inventor. His patents reflect a blend of scientific advancement and practical application, marking him as a key figure in innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile